Kimberly-Clark Corp diskutieren
Kimberly-Clark Corp
WKN: 855178 / Symbol: KMB / Name: Kimberly Clark / Aktie / Persönl. & Haushaltsprodukte & -dienstleistungen / Large Cap /
93,07 €
-0,54 %
Buy Kimberly-Clark Corp
Buy Kimberly-Clark Corp
Buy Kimberly-Clark Corp
Buy Kimberly-Clark Corp
Kimberly-Clark Co. (NYSE: KMB) had its price target lowered by analysts at JPMorgan Chase & Co. from $133.00 to $122.00. They now have an "underweight" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target lowered by analysts at JPMorgan Chase & Co. from $122.00 to $119.00. They now have an "underweight" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $146.00 price target on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $115.00 price target on the stock, down previously from $135.00.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target raised by analysts at JPMorgan Chase & Co. from $119.00 to $125.00. They now have an "underweight" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $135.00 price target on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $150.00 price target on the stock, up previously from $133.00.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target raised by analysts at Piper Sandler from $145.00 to $152.00. They now have an "overweight" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $135.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target raised by analysts at JPMorgan Chase & Co. from $115.00 to $123.00. They now have an "underweight" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target raised by analysts at Bank of America Co. from $110.00 to $115.00. They now have an "underperform" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its price target raised by analysts at Citigroup Inc. from $111.00 to $125.00. They now have a "sell" rating on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $165.00 price target on the stock, up previously from $126.00.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $160.00 price target on the stock, up previously from $115.00.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $165.00 price target on the stock.
Ratings data for KMB provided by MarketBeat
Kimberly-Clark Co. (NYSE: KMB) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for KMB provided by MarketBeat
Neueste Beiträge
Canaccord_Genuity_Gr in Ultragenyx Pharmaceutical Inc. diskutieren